- PFE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3ASR Filing
Pfizer (PFE) S-3ASRAutomatic shelf registration
Filed: 30 Mar 07, 12:00am
New York | 13-5160382 | |
(State of incorporation | (I.R.S. employer | |
if not a U.S. national bank) | identification no.) | |
One Wall Street, New York, N.Y. | 10286 | |
(Address of principal executive offices) | (Zip code) |
Delaware | (I..R.S. employer | |
(State or other jurisdiction of | identification no.) | |
incorporation or organization) | 13-5315170 | |
235 East 42nd Street, New York, NY | 10017-5755 | |
(Address of principal executive offices) | (Zip code) |
1. | General information. Furnish the following information as to the Trustee: |
(a) | Name and address of each examining or supervising authority to which it is subject. |
Name | Address | |
Superintendent of Banks of the State of New York | One State Street, New York, N.Y. 10004-1417, and Albany, N.Y. 12223 | |
Federal Reserve Bank of New York | 33 Liberty Street, New York, N.Y. 10045 | |
Federal Deposit Insurance Corporation | Washington, D.C. 20429 | |
New York Clearing House Association | New York, New York 10005 |
(b) | Whether it is authorized to exercise corporate trust powers. |
Yes. | ||
2. | Affiliations with Obligor. | |
If the obligor is an affiliate of the trustee, describe each such affiliation. | ||
None. | ||
16. | List of Exhibits. | |
Exhibits identified in parentheses below, on file with the Commission, are incorporated herein by reference as an exhibit hereto, pursuant to Rule 7a-29 under the Trust Indenture Act of 1939 (the “Act”) and 17 C.F.R. 229.10(d). |
1. | A copy of the Organization Certificate of The Bank of New York (formerly Irving Trust Company) as now in effect, which contains the authority to commence business and a grant of powers to exercise corporate trust powers. (Exhibit 1 to Amendment No. 1 to Form T-1 filed with Registration Statement No. 33-6215, Exhibits 1a and 1b to Form T-1 filed with Registration Statement No. 33-21672, Exhibit 1 to Form T-1 filed with Registration Statement No. 33-29637 and Exhibit 1 to Form T-1 filed with Registration Statement No. 333-121195.) | ||
4. | A copy of the existing By-laws of the Trustee. (Exhibit 4 to Form T-1 filed with Registration Statement No. 333-121195.) |
- 2 -
6. | The consent of the Trustee required by Section 321(b) of the Act. (Exhibit 6 to Form T-1 filed with Registration Statement No. 333-106702.) | ||
7. | A copy of the latest report of condition of the Trustee published pursuant to law or to the requirements of its supervising or examining authority. |
- 3 -
- 4 -
Dollar Amounts | ||||
In Thousands | ||||
ASSETS | ||||
Cash and balances due from depository institutions: | ||||
Noninterest-bearing balances and currency and coin | $ | 3,375.000 | ||
Interest-bearing balances | 11,937,000 | |||
Securities: | ||||
Held-to-maturity securities | 1,729,000 | |||
Available-for-sale securities | 17,675,000 | |||
Federal funds sold and securities purchased under agreements to resell | ||||
Federal funds sold in domestic offices | 3,953,000 | |||
Securities purchased under agreements to resell | 162,000 | |||
Loans and lease financing receivables: | ||||
Loans and leases held for sale | 0 | |||
Loans and leases, net of unearned income | 30,730,000 | |||
LESS: Allowance for loan and lease losses | 286,000 | |||
Loans and leases, net of unearned income and allowance | 30,444,000 | |||
Trading Assets | 5,047,000 | |||
Premises and fixed assets (including capitalized leases) | 830,000 | |||
Other real estate owned | 1,000 | |||
Investments in unconsolidated subsidiaries and associated companies | 292,000 | |||
Not applicable | ||||
Intangible assets: | ||||
Goodwill | 2,747,000 | |||
Other intangible assets | 981,000 | |||
Other assets | 6,814,000 | |||
Total assets | $ | 85,987,000 | ||
LIABILITIES | ||||
Deposits: | ||||
In domestic offices | $ | 30,000,000 | ||
Noninterest-bearing | 19,293,000 |
Dollar Amounts | ||||
In Thousands | ||||
Interest-bearing | 10,707,000 | |||
In foreign offices, Edge and Agreement subsidiaries, and IBFs | 33,219,000 | |||
Noninterest-bearing | 472,000 | |||
Interest-bearing | 32,747,000 | |||
Federal funds purchased and securities sold under agreements to repurchase | ||||
Federal funds purchased in domestic offices | 671,000 | |||
Securities sold under agreements to repurchase | 185,000 | |||
Trading liabilities | 2,479,000 | |||
Other borrowed money: | ||||
(includes mortgage indebtedness and obligations under capitalized leases) | 2,076,000 | |||
Not applicable | ||||
Not applicable | ||||
Subordinated notes and debentures | 1,955,000 | |||
Other liabilities | 6,527,000 | |||
Total liabilities | $ | 77,112,000 | ||
Minority interest in consolidated subsidiaries | 144,000 | |||
EQUITY CAPITAL | ||||
Perpetual preferred stock and related surplus | 0 | |||
Common stock | 1,135,000 | |||
Surplus (exclude all surplus related to preferred stock) | 2,134,000 | |||
Retained earnings | 5,769,000 | |||
Accumulated other comprehensive income | -307,000 | |||
Other equity capital components | 0 | |||
Total equity capital | 8,731,000 | |||
Total liabilities, minority interest, and equity capital | $ | 85,987,000 | ||
Thomas A. Renyi | ||||
Gerald L. Hassell | Directors | |||
Alan R. Griffith |